Set Back

Discussion in 'Gilead Sciences' started by anonymous, Feb 11, 2019 at 9:24 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


  2. anonymous

    anonymous Guest

    This company has gone to shit. It began with excessive greed in HCV. Now anyone worth their weight is gone and our pipeline is less than promising. What happened to mergers and acquisitions??? Someone save us!
     
  3. anonymous

    anonymous Guest

    Completely Agree. HIV can’t carry this company forever. PAH/IHD and Community HCV folks now gone, no more NASH lifeline and no room in HIV. Overpaid big time for Kite. Time to acquire a company with more promising and further along NASH product and start hiring a year from now.
     
  4. anonymous

    anonymous Guest

    Set back is a kind reference. The leadership was acting as if this was a layup of a product coming along and would transform the liver franchise going forward. Hope you’re ready for a big game of Bulls... bingo going forward.
     
  5. anonymous

    anonymous Guest

    How is it that just a couple of weeks ago this was going to be "huge" and now it's not happening?
    Were those words from stage "staged?""
    How could they NOT have known, just a couple of days before this news was delivered?
     
  6. anonymous

    anonymous Guest

    It will still happen, just after all the current folks in limbo are gone. Look for hiring to begin in a year or so. Probably look first for those left in HCV and HIV that want something new. From there, the remaining 100 or so open sales positions will come from outside Gilead.